February 22, 2021 · Leave a Comment
Mayo Clinic Research in the news — 2/22/2021
Over the last week, Mayo Clinic researchers and expertise have been cited in wide range of news stories, from the ever present COVID-19 to telehealth, participation in cancer clinical trials, creatine supplements, artificial intelligence and more. Read on for headlines, excerpts and links. ‘Knowledge is Power’: Advocating for More Representation in Cancer-Related Clinical Trials Cure, […]
View full entry Comment on this
Tags: Andrew Jagim, artificial intelligence, Bernard Gersh, blood pressure, Brian Pickering, cancer, CAR T-cell therapy, cardiology, cardiovascular medicine, clinical trials, COVID-19, FDA
January 6, 2021 · Leave a Comment
Diverse ways regenerative medicine is advancing health care
Regenerative medicine has contributed to patient care in 2020 more than ever before, bolstered by synergies in research, practice and education. Mayo Clinic’s Center for Regenerative Medicine is at the forefront of a biotherapy revolution in which health care advances from treating disease to restoring health. “The centrality of the body to regenerate itself is […]
View full entry Comment on this
Tags: 3D printing, Andre Terzic, artificial intelligence, Atta Behfar, autoimmune disorder, biomedical engineering, CAR T-cell therapy, Center for Regenerative Medicine, clinical research, clinical trials, data science, fetal surgery
August 11, 2020 · Leave a Comment
Expanding CAR T-cell therapy, welcoming Dr. Qin
The first time Hong Qin, M.D., Ph.D., saw images of how chimeric antigen receptor (CAR) T-cell therapy obliterated a tumor, he was captivated and inspired by this revolutionary treatment. As the new director of Regenerative Immunotherapies at Mayo Clinic in Florida, Dr. Qin and his team will play a pivotal role in accelerating the latest […]
View full entry Comment on this
Tags: blood cancer, CAR T-cell therapy, CAR-T, Center for Regenerative Medicine, Hong Qin, immunotherapy, leukemia, Mayo Clinic Cancer Center, regenerative medicine